Due diligence for potential pipeline asset acquisition - PharmaACE

Case Study

Home / Case Studies / Due diligence for potential pipeline asset acquisition

Due diligence for potential pipeline asset acquisition

Objective

Conduct due diligence to assess a pipeline asset of interest for potential acquisition

Approach

The project was broken into 5 phases

Phase 1: Foundational secondary desk research of market and disease landscape
Phase 2: Qualitative interviews about Target Product Profile (TPP) of focused asset
Phase 3: Sales force sizing for commercial launch
Phase 4: IP Analysis
Phase 5: Forecast revenues to test commercial viability

Outcome

We arrived at details about patient journey, treatment paradigm, competitive landscape and epidemiology triangulation
We conducted primary market research to understand KOL and Payor reactions to TPP
Estimated market reach and time to peak of product share
Executed decision tree analytics of IP
Built revenue forecast model and analyzed sensitivities on key commercial drivers

Client Benefits

This analysis helped the client gain insights into access constraints within a generics-dominated market
The IP analysis provided key data that helped the client create effective business rules for future projects
Based on our recommendation, the client avoided investing in a later-commercially-failed product, protecting resources and mitigating potential losses

BD&L Solutions